I asked ChatGPT which FTSE 100 stocks will surge in 2026

How many FTSE 100 stocks will have a terrific 2026? I consulted ChatGPT for its top 10 picks to surge higher in the year ahead.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Image source: Getty Images

For the FTSE 100, like anything else, a new year brings new opportunities. This was true in January 2025 when some unheralded stocks turned out to have monster years – a few going up multiple times in value.

What will be the Footsie big winners this year? Which big names on the London Stock Exchange might double in value in 2026? I roped my old buddy ChatGPT in to help me get the cogs whirring.

I asked: “Which FTSE 100 stocks will surge in 2026? (Ideally, stocks with a chance to double in value or more.)”

Here was the reponse, separated by tiers:

“📉 Tier 3 — Upside Weighted with Safety / Valuation Appeal” AstraZeneca, GSK, Barclays

“📊 Tier 2 — Strong Upside but More Established”HSBC, Rio Tinto, BP, Shell

“📈 Tier 1 — Highest Upside Potential (Speculative / Cyclical)”Glencore, BAE Systems, RollsRoyce

One of the most striking details of the stocks selected is how large they all are. There are 10 stocks in ChatGPT’s list and they are close to being exactly the same as the largest FTSE 100 stocks by market cap. The top three of AstraZeneca (£211bn market cap), HSBC (£205bn), and Shell (£158bn) are all in there.

Why is this a problem? Because large blue-chip companies tend to be mature. This means they’ve been around a while and offer steady but stable growth rather than being the stocks that surge past all others in any given year.

That’s not to say AstraZeneca couldn’t surge in 2026. A new blockbuster drug or two might pop along to send the share into orbit. But it’s a lot harder to double up when we’re already dealing with numbers in the hundreds of billions.

A banner year?

With all that said, the number one spot on the list is occupied by Rolls-Royce (LSE: RR.) and I won’t be disagreeing with that. The share price has been rocketing in recent years after success in its sales of engines for consumer and military aircraft along with increasing demand for other types of power systems too.

As with any stock that has been surging, it pays to look at the valuation. How much am I paying for a Rolls-Royce share compared to earnings? As Warren Buffett is fond of saying: “Price is what you pay but value is what you get.”

The Rolls-Royce forward price-to-earnings ratio stands at 36. That’s pretty high compared to the FTSE 100 average of 19. While an elevated P/E ratio does suggest investors like the look of a stock’s long term prospects, it means a lot of future growth is already baked into the price you are paying.

For Rolls-Royce to surge next year looks unlikely now – a double would take it to biggest Footsie firm by market cap – but there were a lot of naysayers at the start of 2025 too and look how that turned out. I’d call the stock worth considering.

HSBC Holdings is an advertising partner of Motley Fool Money. John Fieldsend has positions in AstraZeneca Plc, BAE Systems, Glencore Plc, Rio Tinto Group, Rolls-Royce Plc, and Shell Plc. The Motley Fool UK has recommended AstraZeneca Plc, BAE Systems, GSK, HSBC Holdings, and Rolls-Royce Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two white male workmen working on site at an oil rig
Investing Articles

As oil prices soar, is it time to buy Shell shares?

Christopher Ruane weighs some pros and cons of adding Shell shares to his ISA -- and explains why the oil…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

How much do you need in an ISA for £6,751 passive income a year in 2046?

Let's say an investor wanted a passive income in 20 years' time. How much cash would need be built up…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Why isn’t the IAG share price crashing?

Harvey Jones expected the IAG share price to take an absolute beating during current Middle East hostilities. So why is…

Read more »

piggy bank, searching with binoculars
Growth Shares

1 UK share I’d consider buying and 1 I’d run away from on this market dip

In light of the recent stock market dip, Jon Smith outlines the various potential outcomes for a couple of different…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

AI may look like a bubble. But what about Rolls-Royce shares?

Bubble talk has been centred on some AI stocks lately. But Christopher Ruane sees risks to Rolls-Royce shares in the…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Will the BAE Systems share price soar 13% by this time next year?

BAE Systems' share price continues to surge as the Middle East crisis worsens. Royston Wild asks if the FTSE 100…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is this a once-in-a-decade chance to bag a 9.9% yield from Taylor Wimpey shares?

Taylor Wimpey shares have been hit by a volatile share price and cuts to the dividend. Harvey Jones holds the…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Way up – or way down? This FTSE 250 share could go either way

Can this FTSE 250 share turn its fortunes around? Or has its day passed? Our writer looks at both sides…

Read more »